Abbott Appeals $1.9B Hit In Patent Suit Over Humira

By Brendan Pierson

Law360, New York (December 22, 2009, 12:05 PM ET) -- Abbott Laboratories is appealing a $1.85 billion judgment imposed against it after a jury found that the drugmaker's arthritis treatment Humira infringed a patent asserted by Johnson & Johnson unit Centocor Ortho Biotech Inc.

Abbott filed a notice of appeal Monday in the U.S. District Court for the Eastern District of Texas, taking the case to the U.S. Court of Appeals for the Federal Circuit.

Judge T. John Ward entered final judgment in the case on Friday, adding interest of nearly $176 million on the record...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles